Lux MP - Search Results

1

Diabetes and prognosis in a breast cancer cohort.

Schrauder MG, Fasching PA, Häberle L, Lux MP, Rauh C, Hein A, Bayer CM, Heusinger K, Hartmann A, Strehl JD, Wachter DL, Schulz-Wendtland R, Adamietz B, Beckmann MW, Loehberg CR. Schrauder MG, et al. Among authors: lux mp. J Cancer Res Clin Oncol. 2011 Jun;137(6):975-83. doi: 10.1007/s00432-010-0960-2. Epub 2010 Dec 5. J Cancer Res Clin Oncol. 2011. PMID: 21132511

2

[Breast cancer: assessment of individual risk and possibilities for prevention].

Kuschel B, Aba F, Lux M, Jap D, Bender HG, Beckmann MW. Kuschel B, et al. Z Arztl Fortbild Qualitatssich. 2000 Apr;94(3):231-7. Z Arztl Fortbild Qualitatssich. 2000. PMID: 10802899 Review. German.

3

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.

Kuschel B, Lux MP, Goecke TO, Beckmann MW. Kuschel B, et al. Among authors: lux mp. Eur J Cancer Prev. 2000 Jun;9(3):139-50. Eur J Cancer Prev. 2000. PMID: 10954253 Review.

4

Awareness of breast cancer incidence and risk factors among healthy women.

Pöhls UG, Renner SP, Fasching PA, Lux MP, Kreis H, Ackermann S, Bender HG, Beckmann MW. Pöhls UG, et al. Among authors: lux mp. Eur J Cancer Prev. 2004 Aug;13(4):249-56. doi: 10.1097/01.cej.0000136718.03089.a5. Eur J Cancer Prev. 2004. PMID: 15554551

5

Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancer.

Lux MP, Ackermann S, Nestle-Krämling C, Goecke TO, Niederacher D, Bodden-Heidrich R, Bender HG, Beckmann MW, Fasching PA. Lux MP, et al. Eur J Cancer Prev. 2005 Aug;14(4):399-411. doi: 10.1097/00008469-200508000-00014. Eur J Cancer Prev. 2005. PMID: 16030432

6

Neoadjuvant chemotherapy in breast cancer: which diagnostic procedures can be used?

Loehberg CR, Lux MP, Ackermann S, Poehls UG, Bani MR, Schulz-Wendtland R, Papadopoulos T, Schmucker M, Beckmann MW, Fasching PA. Loehberg CR, et al. Among authors: lux mp. Anticancer Res. 2005 May-Jun;25(3c):2519-25. Anticancer Res. 2005. PMID: 16080487 Free article.

7

Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself*.

Heusinger K, Löhberg C, Lux MP, Papadopoulos T, Imhoff K, Schulz-Wendtland R, Beckmann MW, Fasching PA. Heusinger K, et al. Among authors: lux mp. Breast Cancer Res Treat. 2005 Nov;94(1):17-23. doi: 10.1007/s10549-005-6653-x. Breast Cancer Res Treat. 2005. PMID: 16142441

8

[Prophylactic surgery of mammary and ovarian carcinoma].

Lux MP, Bani MR, Fasching PA, Beckmann MW. Lux MP, et al. Chirurg. 2005 Dec;76(12):1145-54. doi: 10.1007/s00104-005-1100-4. Chirurg. 2005. PMID: 16237564 Review. German.

9

Hereditary breast and ovarian cancer: review and future perspectives.

Lux MP, Fasching PA, Beckmann MW. Lux MP, et al. J Mol Med (Berl). 2006 Jan;84(1):16-28. doi: 10.1007/s00109-005-0696-7. Epub 2005 Nov 11. J Mol Med (Berl). 2006. PMID: 16283147 Review.

10

Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer.

Lux MP, Ackermann S, Bani MR, Nestle-Krämling C, Goecke TO, Niederacher D, Bodden-Heidrich R, Bender HG, Beckmann MW, Fasching PA. Lux MP, et al. Eur J Cancer Prev. 2005 Dec;14(6):503-11. doi: 10.1097/00008469-200512000-00003. Eur J Cancer Prev. 2005. PMID: 16284494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters